Tabula Rasa Healthcare Stock Revenue
Tabula Rasa HealthCare fundamentals help investors to digest information that contributes to Tabula Rasa's financial success or failures. It also enables traders to predict the movement of Tabula Stock. The fundamental analysis module provides a way to measure Tabula Rasa's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tabula Rasa stock.
Tabula |
Tabula Rasa HealthCare Company Revenue Analysis
Tabula Rasa's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Tabula Rasa Revenue | 299.52 M |
Most of Tabula Rasa's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tabula Rasa HealthCare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Tabula Rasa HealthCare reported 299.52 M of revenue. This is 96.07% lower than that of the Health Care Technology sector and significantly higher than that of the Health Care industry. The revenue for all United States stocks is 96.83% higher than that of the company.
Tabula Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tabula Rasa's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tabula Rasa could also be used in its relative valuation, which is a method of valuing Tabula Rasa by comparing valuation metrics of similar companies.Tabula Rasa is currently under evaluation in revenue category among its peers.
Tabula Fundamentals
| Return On Equity | -5.55 | |||
| Return On Asset | -0.0598 | |||
| Profit Margin | (0.28) % | |||
| Operating Margin | (0.06) % | |||
| Current Valuation | 548.09 M | |||
| Shares Outstanding | 27.05 M | |||
| Shares Owned By Insiders | 12.09 % | |||
| Shares Owned By Institutions | 70.69 % | |||
| Number Of Shares Shorted | 732.92 K | |||
| Price To Earning | 67.61 X | |||
| Price To Book | 3.69 X | |||
| Price To Sales | 0.34 X | |||
| Revenue | 299.52 M | |||
| Gross Profit | 66.91 M | |||
| EBITDA | (24.64 M) | |||
| Net Income | (147.51 M) | |||
| Cash And Equivalents | 26.52 M | |||
| Cash Per Share | 1.11 X | |||
| Total Debt | 336.13 M | |||
| Current Ratio | 1.73 X | |||
| Book Value Per Share | (3.05) X | |||
| Cash Flow From Operations | 7.36 M | |||
| Short Ratio | 3.29 X | |||
| Earnings Per Share | (2.46) X | |||
| Price To Earnings To Growth | 7.29 X | |||
| Target Price | 10.5 | |||
| Number Of Employees | 1.03 K | |||
| Beta | 1.57 | |||
| Market Capitalization | 284.03 M | |||
| Total Asset | 384.15 M | |||
| Retained Earnings | (407.86 M) | |||
| Working Capital | 68.18 M | |||
| Current Asset | 12.13 M | |||
| Current Liabilities | 51.57 M | |||
| Z Score | -0.2 | |||
| Net Asset | 384.15 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in Tabula Stock
If you are still planning to invest in Tabula Rasa HealthCare check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tabula Rasa's history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |